NASHVILLE, Tenn., Dec. 4 /PRNewswire/ -- Cumberland Emerging
Technologies, Inc. (CET) (http://www.cet-fund.com/) today announced that
Insight Genetics, Inc. has secured lab and office space at the CET Life
Sciences Center in downtown Nashville, which is adjacent to the Union
A spin-off of Nashville-based Genetic Assays, Inc., Insight Genetics
was formed in January 2007 to improve the quality, safety and efficiency of
disease diagnosis and treatment and make a new level of targeted drug
therapy possible. The company has created a patented, highly specific
genetic screening technology -- Template Exchange Extension Reaction
(TEER(TM)) -- that will be a powerful tool in the emerging personalized
Insight Genetics is exploring initial commercial applications for its
TEER technology within cancer drug rescue, discovery and development, as
well as early cancer detection and monitoring. The company is currently
seeking partnerships that will accelerate the commercialization of TEER.
"CET is an excellent partner for early-stage and emerging bioscience
companies," said Eric Dahlhauser, chief executive officer of Insight
Genetics. "The support, expertise and resources CET provides companies like
ours are unmatched in this region and the Life Sciences Center in downtown
Nashville provides a great, central site for Insight Genetics as we grow."
The CET Life Sciences Center provides lab and office space, equipment
and infrastructure support to several tenants, including the Tennessee
Biotechnology Association, which has established its headquarters at the
"We are very pleased to welcome Insight Genetics to the Life Sciences
Center," said A.J. Kazimi, chief executive officer of CET and Cumberland
Pharmaceuticals Inc. "Their exciting new technology holds great promise for
patient care, and we look forward to helping them grow through the start-up
phase and on to commercial viability."
Cumberland Emerging Technologies, Inc. (www.cet-fund.com) is a joint
initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University
and the Tennessee Technology Development Corporation. The mission of CET is
to bring biomedical technologies and products conceived at Vanderbilt and
other regional research centers to the marketplace. CET helps manage the
development and commercialization process for select projects, and provides
expertise on intellectual property, regulatory, manufacturing and marketing
issues that are critical to successful new biomedical products. CET's Life
Sciences Center, located in Nashville, Tennessee, provides laboratory
space, equipment and infrastructure to early-stage life sciences companies.
SOURCE Cumberland Emerging Technologies, Inc.